ProfileGDS4718 / 226282_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 73% 75% 99% 72% 79% 80% 76% 74% 76% 75% 74% 79% 83% 80% 83% 84% 80% 85% 84% 93% 78% 80% 77% 79% 79% 82% 81% 87% 75% 76% 85% 92% 75% 63% 89% 90% 67% 79% 69% 99% 73% 73% 95% 89% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.1290973
GSM549102patient 115, normal, homogenized [OPG study]7.2347875
GSM549104patient 119, normal, homogenized [OPG study]12.324899
GSM549108patient 138, normal, homogenized [OPG study]7.034772
GSM549119patient 077, normal, homogenized [OPG study]7.6597179
GSM549133patient 032, cancer, homogenized [OPG study]8.021380
GSM549139patient 042, cancer, homogenized [OPG study]7.4905176
GSM549099patient 107, normal, homogenized [OPG study]7.1182974
GSM549109patient 139, normal, homogenized [OPG study]7.3808176
GSM549110patient 046, normal, homogenized [OPG study]7.278675
GSM549114patient 063, normal, homogenized [OPG study]7.26374
GSM549122patient 082, normal, homogenized [OPG study]7.7761379
GSM549134patient 033, cancer, homogenized [OPG study]8.2368483
GSM549136patient 036, cancer, homogenized [OPG study]7.9523780
GSM549140patient 044, cancer, homogenized [OPG study]8.2717883
GSM549111patient 047, normal, homogenized [OPG study]8.3562884
GSM549113patient 057, normal, homogenized [OPG study]7.9053180
GSM549132patient 031, cancer, homogenized [OPG study]8.5212285
GSM549137patient 038, cancer, homogenized [OPG study]8.2976884
GSM549142patient 047, cancer, homogenized [OPG study]9.3063293
GSM549100patient 110, normal, homogenized [OPG study]7.5108978
GSM549107patient 135, normal, homogenized [OPG study]7.8262780
GSM549115patient 068, normal, homogenized [OPG study]7.5830577
GSM549116patient 072, normal, homogenized [OPG study]7.7993979
GSM549120patient 078, normal, homogenized [OPG study]7.763379
GSM549131patient 030, cancer, homogenized [OPG study]8.1542482
GSM549118patient 074, normal, homogenized [OPG study]7.9781681
GSM549129patient 027, cancer, homogenized [OPG study]8.639787
GSM549123patient 088, normal, homogenized [OPG study]7.3013975
GSM549124patient 006, cancer, homogenized [OPG study]7.3669576
GSM549126patient 015, cancer, homogenized [OPG study]8.4146385
GSM549128patient 025, cancer, homogenized [OPG study]9.4800792
GSM549103patient 117, normal, homogenized [OPG study]7.2212175
GSM549117patient 073, normal, homogenized [OPG study]6.255563
GSM549138patient 041, cancer, homogenized [OPG study]9.0712189
GSM549141patient 045, cancer, homogenized [OPG study]9.2771390
GSM549130patient 028, cancer, homogenized [OPG study]6.6131367
GSM549101patient 111, normal, homogenized [OPG study]7.7431879
GSM549105patient 128, normal, homogenized [OPG study]6.821469
GSM549106patient 134, normal, homogenized [OPG study]12.210399
GSM549112patient 048, normal, homogenized [OPG study]7.1254573
GSM549125patient 011, cancer, homogenized [OPG study]7.1382373
GSM549127patient 024, cancer, homogenized [OPG study]10.206695
GSM549135patient 035, cancer, homogenized [OPG study]9.0404289